Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-osteoporosis strategies in renal transplant recipients
ChiCTR-TRC-11001734Phase 4Completed
- Sponsor
- The Third Medical Center of the Chinese People's Liberation Army General Hospital
- Start
- Jan 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of calcium carbonate + cholecalciferol, calcitriol, TBRIA and alendronate in osteoporosis (6 arms), sponsored by The Third Medical Center of the Chinese People's Liberation Army General Hospital. Primary endpoints: Bone mineral density, Beta-cross laps and 3 more. Started Jan 2012; status: completed.
02
Drugs
calcium carbonate + cholecalciferolcalcitriolTBRIAalendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on ChiCTR-TRC-11001734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001734.